<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04784169</url>
  </required_header>
  <id_info>
    <org_study_id>20210086</org_study_id>
    <nct_id>NCT04784169</nct_id>
  </id_info>
  <brief_title>Free Middle Turbinate Flap for Repair of Low Flow Cerebrospinal Fluid Leak</brief_title>
  <official_title>Free Middle Turbinate Flap for Repair of Low Flow Cerebrospinal Fluid Leak</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wuhan Union Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Limited literature has been reported the use of free middle turbinate flap during an&#xD;
      endoscopic approach to treat cerebrospinal fluid (CSF) leak, and the results were&#xD;
      inconclusive. The overall purpose of this study was to assess the efficacy and safety of free&#xD;
      middle turbinate flap in reparing CSF leak during an endoscopic approach.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cerebrospinal fluid (CSF) rhinorrhea results from an abnormal communication between the&#xD;
      sinonasal cavity and the subarachnoid space. It may occur spontaneously or secondary to&#xD;
      accidental or iatrogenic trauma. CSF leak is a potentially devastating condition that can&#xD;
      lead to ascending meningitis, pneumocephalus, and intracranial abscess. Surgical repair is&#xD;
      recommended for most patients with CSF leaks to prevent the potential sequelae.&#xD;
&#xD;
      Multiple graft materials have been employed in the approach, including temporalis fascia,&#xD;
      middle turbinate flap, fascia lata, fat, free cartilage or bone, vascularized nasoseptal flap&#xD;
      and acellular skin grafts. Among these options, vascular nasoseptal ï¬‚aps are the most popular&#xD;
      materials at present. Limited literature has been reported the use of free middle turbinate&#xD;
      flap during an endoscopic approach to treat CSF rhinorrhea, and the results were&#xD;
      inconclusive. There were a large number of cases using free middle turbinate flap for CSF&#xD;
      rhinorrhea repair in our institution. The purpose of this study was to determine the efficacy&#xD;
      and safety of the free middle turbinate flap for repair of CSF rhinorrhea.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2021</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Cerebrospinal Fluid (CSF) Leak</measure>
    <time_frame>1month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Postoperative Complications</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>CSF Leakage</condition>
  <arm_group>
    <arm_group_label>free middle turbinate flap group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A free middle turbinate flap is used to repair the leakage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vascularized nasoseptal flap</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A vascularized nasoseptal flap is used to repair the leakage</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>free middle turbinate flap</intervention_name>
    <description>Repairing low flow leak using free middle turbinate flap</description>
    <arm_group_label>free middle turbinate flap group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>vascularized nasoseptal flap</intervention_name>
    <description>Repairing low flow leak using fascia lata</description>
    <arm_group_label>vascularized nasoseptal flap</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing repairing of CSF leak under transsphenoidal approach&#xD;
&#xD;
          -  Dural defect smaller than 1cm&#xD;
&#xD;
          -  No extensive arachnoid dissection&#xD;
&#xD;
          -  No dissection into a ventricle or cistern&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  High flow CSF leak&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GAO HUI</last_name>
    <role>Study Chair</role>
    <affiliation>Wuhan Union Hospital, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Qiangping Wang, MD</last_name>
    <phone>+8613476850638</phone>
    <email>kouxiangtang7595@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qiangping Wang</last_name>
    <email>kouxiangtang7595@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>GAO HUI</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>GAO HUI</last_name>
      <phone>+8613476850638</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 8, 2021</study_first_submitted>
  <study_first_submitted_qc>March 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>March 3, 2021</last_update_submitted>
  <last_update_submitted_qc>March 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wuhan Union Hospital, China</investigator_affiliation>
    <investigator_full_name>Qiangping Wang</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebrospinal Fluid Leak</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

